We build biologics and cell therapies by integrating disease biology, translational biomarkers, and computational pipelines. Our focus is solid tumours and ageing-related disease mechanisms, including cellular senescence.
Programs designed for the constraints of solid tumours, including tumour microenvironment and immune evasion.
Age-related disorders
Programs anchored in ageing-related biology, with emphasis on immunosenescence, chronic inflammation, tissue dysfunction, and senescence-linked mechanisms.